Nexien Biopharma Inc (NXEN) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nexien Biopharma Inc   (NXEN)


Nexien Biopharma Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nexien Biopharma Inc's ROI in the third quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Nexien Biopharma Inc 's return on investment (ROI) in its third quarter of 2025

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
III. Quarter		 (Dec 31 2024)
II. Quarter		 (Sep 30 2024)
I. Quarter		 (Jun 30 2024)
IV. Quarter		 (Mar 31 2024)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 0 0 0 0
Return On Investment (TTM) - - - - -
NXEN's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

NXEN Company Profile >> Back to NXEN Roi Comparisons >> See Annual NXEN Return On Investment



Return On Investment NXEN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Nexien Biopharma Inc's III. Quarter Investments $ 0 Millions NXEN's Balance sheet
Nexien Biopharma Inc's III. Quarter Income $ 0 Millions Quarterly NXEN's Income Statement
NXEN's Income by Division See NXEN's Income by Division


NXEN Annual Return On Investment (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Jun 30 2020)
2020
Total Investments in Millions 0 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 0 0 -1 -2 -3
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NXEN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NXEN's Competitors
Subscribers only: Roi for Nexien Biopharma Inc's Suppliers
Subscribers only: Return On Investment for NXEN's Customers

Other Ratios
NXEN's Roa NXEN's Inventory Turnover Ratio NXEN's Growth Rates NXEN's Dividend Statistics
NXEN's Profitability Ratios NXEN's Asset Turnover Ratio NXEN's Dividend Growth
NXEN's Roe NXEN's Valuation Ratios NXEN's Financial Strength Ratios NXEN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI
Alumis inc   113.83 %
Stablecoin Development Corporation  110.75 %
Earth Science Tech Inc   100.58 %
Oak Woods Acquisition Corp  93.88 %
Avalo Therapeutics Inc   88.86 %
Tao Synergies Inc   78.95 %
Synlogic Inc   73.65 %
Novavax inc   71.31 %
Medinotec Inc   60.77 %
Exelixis Inc   59.41 %
Gridai Technologies Corp  58.38 %
Longduoduo Co Ltd  56.87 %
Adma Biologics Inc   53.77 %
Bluebird Bio Inc   52.44 %
Seres Therapeutics Inc   52.22 %
Pharmacyte Biotech Inc   48.77 %
Agios Pharmaceuticals Inc   48.46 %
Dariohealth Corp   44.97 %
Sbc Medical Group Holdings Incorporated  41.74 %
Champions Oncology Inc   41.16 %
Ptc Therapeutics inc   40.79 %
Rigel Pharmaceuticals Inc  39.96 %
Mettler toledo International Inc   39.75 %
Idexx Laboratories Inc  39.40 %
Edwards Lifesciences Corporation  38.53 %
Puma Biotechnology Inc   34.10 %
Hims and Hers Health Inc   34.04 %
Medpace Holdings Inc   33.49 %
Acadia Pharmaceuticals Inc   32.33 %
Nutriband Inc   30.51 %

Date modified: 2026-09-08T15:11:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.